Evidence map›Paper›PMID 37654626›Full record

ArticleCancer research communications2023

Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes.

Tingting Qin, Shiting Li, Leanne E Henry, Elysia Chou, Raymond G Cavalcante, Bailey F Garb, Nisha J D'Silva, Laura S Rozek, Maureen A Sartor

Open access · goldAbstract read
In one paragraph

Article in Cancer research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tingting Qin *Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0003-3810-7578
Shiting Li *Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0002-9074-8957
Leanne E HenryDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0009-0003-7554-079X
Elysia ChouDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0002-1007-4455
Raymond G CavalcanteDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0002-6986-4283
Bailey F GarbDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0002-9230-054X
Nisha J D'SilvaDepartment of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-7030-3187
Laura S RozekDepartment of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6731-7000
Maureen A SartorDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0001-6155-5702
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Strategies to Overcome Immune Resistance in Head and Neck CancersP01CA240239 · NCI · YALE UNIVERSITY · PI SARTOR, MAUREEN AGNES · 2019 to 2023
$8.4M
Proteogenomics of Cancer Training ProgramT32CA140044 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, ARVIND, SARTOR, MAUREEN AGNES · 2010 to 2024
$3.9M
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancerR01CA250214 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI D'SILVA, NISHA J, ROZEK, LAURA · 2020 to 2024
$3.1M
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-R01CA158286 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROZEK, LAURA, SARTOR, MAUREEN AGNES · 2011 to 2015
$2.6M
NCI NIH HHS P01 CA240239NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA158286NCI NIH HHS R01 CA250214NCI NIH HHS T32 CA140044NIEHS NIH HHS P30 ES017885
6 · The paper itself

Abstract

DNA methylation is a vital early step in carcinogenesis. Most findings of aberrant DNA methylation in head and neck squamous cell carcinomas (HNSCC) are array based with limited coverage and resolution, and mainly explored by human papillomavirus (HPV) status, ignoring the high heterogeneity of this disease. In this study, we performed whole-genome bisulfite sequencing on a well-studied HNSCC cohort ( Significance: This study revealed that the previously observed hypermethylation of HPV(+) HNSCC is due solely to the IMU subtype, illustrating the importance of fine-scale subtype analysis in such a heterogeneous disease. Particularly, IMU has significantly higher methylation of transposable elements, which can be tested as a prognosis biomarker in future translational studies.

Indexed as

Head and Neck NeoplasmsPapillomavirus InfectionsCarcinogenesisDNA MethylationGenomic InstabilityHuman Papillomavirus VirusesHumansSquamous Cell Carcinoma of Head and Neck

Identifiers

PMID37654626
PMCPMC10467604
OpenAlexW4385892336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.